Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37

References

• Flodgaard HE, Ostergaard E, Bayne S, . Covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin. Neutrophile elastase homologues with strong monocyte and fibroblast chemotactic activities. Eur J Biochem 1991; 197: 535–547.
   PubMedGoogle Scholar
• Gabay JE, Scott RW, Campanelli D, . Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci (USA) 1989; 86: 5610–5614.
   PubMed Web of Science ®Google Scholar
• Shafer WM, Martin LE, Spitznagel JK. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun 1984; 45: 29–35.
   PubMed Web of Science ®Google Scholar
• Shafer WM, Martin LE, Spitznagel JK. Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granulocytes. Infect Immun 1986; 53: 651–655.
   PubMed Web of Science ®Google Scholar
• Spitznagel JK. Antibiotic proteins of human neutrophils. J Clin Invest 1990; 86: 1381–1386.
   PubMedGoogle Scholar
• Pereira HA, Shafer WM, Pohl J, Martin LE, Spitznagel JK. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest 1990; 85: 1468–1476.
   PubMed Web of Science ®Google Scholar
• Pereira HA, Ruan X, Kumar P. Activation of microglia: a neuroinflammatory role for CAP37. GLIA 2003; 41: 64–72.
   PubMedGoogle Scholar
• Morgan JG, Pereira HA, Sukiennicki T, Spitznagel JK, Larrick JW. Human neutrophil granule cationic protein CAP37 is a specific macrophage chemotaxin that shares homology with inflammatory proteinases. Adv Ex Med Biol 1991; 305: 89–96.
   PubMedGoogle Scholar
• Ruan X, Chodosh J, Callegan MC, . Corneal expression of the inflammatory mediator CAP37. Invest Ophthalmol Vis Sci 2002; 43: 1414–1421.
   PubMed Web of Science ®Google Scholar
• Lee TD, Gonzalez ML, Kumar P, . CAP37, a novel inflammatory mediator. Its expression in endothelial cells and localization to atherosclerotic lesions. Am J Pathol 2002; 160: 841–848.
   PubMedGoogle Scholar
• Lee TD, Gonzalez ML, Kumar P, Grammas P, Pereira HA. CAP37, a neutrophil-derived inflammatory mediator augments leukocyte adhesion to endothelial monolayers. Microvasc Res 2003; 66: 38–48.
   PubMedGoogle Scholar
• Gonzalez ML, Ruan X, Kumar P, Grammas P, Pereira HA. Functional modulation of smooth muscle cells by the inflammatory mediator CAP37. Microvasc Res 2004; 67: 168–181.
   PubMedGoogle Scholar
• Pereira HA, Erdem I, Pohl J, Spitznagel JK. Synthetic bactericidal peptide based on CAP37: a 37 kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci (USA) 1993; 90: 4733–4737.
   PubMed Web of Science ®Google Scholar
• Brackett DJ, Lerner MR, Lacquement MA, He R, Pereira HA. A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats. Infect Immun 1997; 65: 2803–2811.
   PubMed Web of Science ®Google Scholar
• Hubalek F, Edmondson DE, Pohl J. Synthesis and characterization of a collagen model. dO-phosphohydroxylysine-containing peptide. Anal Biochem 2002; 306: 124–134.
   PubMedGoogle Scholar
• Pohl J, Pereira HA, Martin NM, Spitznagel JK. Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase. FEBS Lett 1990; 272: 200–204.
   PubMedGoogle Scholar
• Moroder L. Isoteric replacement of sulfur with other chalcogens in peptides and proteins. J Peptide Science 2005; 11: 187–214.
   PubMed Web of Science ®Google Scholar
• Kadosh D, Johnson AD. Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: a genome-wide analysis. Mol Biol 2005; 16: 2903–2912.
   Google Scholar
• Vylkova S, Li XS, Berner JC, Edgerton M. Distinct antifungal mechanisms: beta defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob Agents Chemother 2006; 50: 324–331.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Mukherjee PK, Clark TA, . Candida parapsilosis. Characterization in an outbreak setting. Emerging Infect Dis 2004; 10: 1074–1081.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Peacock JE, Tanner DC, . Therapeutic approaches in patients with candidemia: evaluation in a multi-center prospective observational study. Arch Intern Med 1995; 155: 2429–2435.
   PubMed Web of Science ®Google Scholar
• Warn PA, Sharp A, Morrissey G, Denning DW. In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis. J Antimicrob Agents Chemother 2002; 50: 1071–1074.
   Google Scholar
• Sullivan DJ, Morgan GP, Pinjon E, . Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369–376.
   PubMed Web of Science ®Google Scholar
• Clark TA, Hajjeh RA. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002; 15: 569–574.
   PubMed Web of Science ®Google Scholar
• Hobson RP. The global epidemiology of invasive Candida infections – is the tide turning? J Hosp Infect 2003; 55: 159–168.
   PubMed Web of Science ®Google Scholar
• Rapp RP. Changing strategies for the management of invasive fungal infections. Pharmacotherapy 2004; 24: 4S–28S.
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerging Infect Dis 2004; 10: 14–19.
   PubMed Web of Science ®Google Scholar
• Ganz T, Weiss J. Antimicrobial peptides of phagocytes and epithelial. Semin Hematol 1997; 34: 343–354.
   PubMed Web of Science ®Google Scholar
• Hancock REW. Peptide antibiotics. Lancet 1997; 349: 418–422.
   PubMed Web of Science ®Google Scholar
• Hoover DM, Wu Z, Tucke K, Lu W, Lubkowski J. Antimicrobial characterization of human β-defensin 3 derivatives. Antimicrob Agents Chemother 2003; 47: 2804–2809.
   PubMed Web of Science ®Google Scholar
• Selsted ME, Szklarek D, Ganz T, Lehrer RI. Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun 1985; 49: 202–206.
   PubMed Web of Science ®Google Scholar
• Edgerton M, Koshlukova SE, Araujo MWB, . Salivary histatin 5 and human neutrophil defensins 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother 2000; 44: 3310–3316.
   PubMed Web of Science ®Google Scholar
• Tsai H, Bobek LA. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species. Antimicrob Agents Chemother 1997; 41: 2224–2228.
   PubMedGoogle Scholar
• Tsai H, Raj PA, Bobek LA. Candidacidal activity of recombinant human salivary histatin-5 and variants. Infect Immun 1996; 64: 5000–5007.
   PubMed Web of Science ®Google Scholar
• Lupetti A, Paulusma-Annema A, Welling MM, . Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother 2000; 44: 3257–3263.
   PubMed Web of Science ®Google Scholar
• Viejo-Diaz M, Andrés MT, Fierro JF. Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and Kaliocin-1. Antimicrob Agents Chemother 2005; 49: 2583–2588.
   PubMed Web of Science ®Google Scholar
• Helmerhorst EJ, Van ‘T Hof W, Veerman ECI, Simoons-Smit I, Nieuw Amerongen AV. Synthetic histatin analogues with broad spectrum antimicrobial activity. Biochem J 1997; 326: 39–45.
   PubMed Web of Science ®Google Scholar
• Helmerhorst EJ, Reijnders IM, Van ‘T Hof W, . Amphotericin B- and Fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother 1999; 43: 702–704.
   PubMed Web of Science ®Google Scholar
• Tang Y-Q, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002; 70: 6524–6533.
   PubMed Web of Science ®Google Scholar
• Den Hertog AL, Van Marle J, Van Veen HA, . Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J 2005; 388: 689–695.
   PubMed Web of Science ®Google Scholar
• Pereira HA, Kumar P, Grammas P. Expression of CAP37, a novel inflammatory mediator in Alzheimer's disease. Neurobiol Aging 1996; 17: 753–759.
   PubMed Web of Science ®Google Scholar
• Pereira HA, Kumar P, Lerner MR, Brackett DJ. Inducible expression of the inflammatory protein CAP37 in the epidermis during wound healing. Robinson JW. Focus on Protein Research. Hauppauge NY: Nova Biomedical Publications2004; :127–144.
   Google Scholar
• Nizet V, Ohtake T, Lauth X, . Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414: 454–457.
   PubMed Web of Science ®Google Scholar
• Oren A, Ganz T, Liu L, Meerloo T. In human epidermis, beta defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 2003; 74: 180–182.
   PubMedGoogle Scholar
• Shirafuji Y, Oono T, Kanzaki H, Hirakawa S, Arata J. Detection of cryptdin in mouse skin. Clin Diagn Lab Immunol 1999; 6: 336–340.
   PubMedGoogle Scholar
• Sørensen OE, Cowland JB, Theilgaard-Mönch K, . Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003; 170: 5583–5589.
   PubMed Web of Science ®Google Scholar
• Fellermann K, Stange EF. Defensins – innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 2001; 13: 771–776.
   PubMedGoogle Scholar
• Frohm-Nilsson M, Sandstedt B, Sørensen O, . M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999; 67: 2561–2566.
   PubMed Web of Science ®Google Scholar
• Dale BA. Periodontal epithelium: a newly recognized role in health and disease. Periodontal 2003; 30: 70–78.
   Google Scholar
• Dale BA, Krisanaprakornkit S.Defensin antimicrobial peptides in the oral cavity. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 200; ; 30: :321–327..
   Google Scholar
• Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 2000; 173: 27–38.
   PubMed Web of Science ®Google Scholar
• Hiemstra PS. Epithelial antimicrobial peptides and proteins: their role in host defense and inflammation. Pediatr Respir Rev 2001; 2: 306–310.
   PubMedGoogle Scholar
• Huttner KM, Bevins CL. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 1999; 45: 785–794.
   PubMed Web of Science ®Google Scholar
• Malm J, Sørensen O, Persson T, . The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations and is attached to spermatozoa. Infect Immun 2000; 68: 4297–4302.
   PubMed Web of Science ®Google Scholar